Group One Trading
IRWD icon

Group One Trading’s Ironwood Pharmaceuticals IRWD Stock Holding History

Group One Trading’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$285K Sell
81,100
-161,000
-67% -$660K ﹤0.01% 3850
2025
Q4 		$816K Buy
242,100
+240,700
+17,193% +$625K ﹤0.01% 3081
2025
Q3 		$1.83K Sell
1,400
-3,600
-72% -$3.73K ﹤0.01% 7919
2025
Q2 		$3.59K Buy
5,000
+4,900
+4,900% +$3.85K ﹤0.01% 7226
2025
Q1 		$147 Buy
+100
New +$238 ﹤0.01% 7389
2024
Q4 		– Sell
-10,000
Closed -$41.2K – 7600
2024
Q3 		$41.2K Buy
10,000
+4,700
+89% +$25.3K ﹤0.01% 4774
2024
Q2 		$34.6K Sell
5,300
-436,900
-99% -$3.09M ﹤0.01% 4800
2024
Q1 		$3.85M Buy
442,200
+358,400
+428% +$4.35M 0.01% 1005
2023
Q4 		$959K Buy
83,800
+80,600
+2,519% +$797K ﹤0.01% 2491
2023
Q3 		$30.8K Sell
3,200
-22,100
-87% -$217K ﹤0.01% 5519
2023
Q2 		$269K Buy
25,300
+21,900
+644% +$235K ﹤0.01% 3642
2023
Q1 		$35.8K Sell
3,400
-54,800
-94% -$614K ﹤0.01% 5108
2022
Q4 		$721K Buy
58,200
+27,000
+87% +$306K ﹤0.01% 2707
2022
Q3 		$323K Sell
31,200
-6,200
-17% -$70.3K ﹤0.01% 3664
2022
Q2 		$431K Buy
37,400
+30,300
+427% +$357K ﹤0.01% 3572
2022
Q1 		$89K Sell
7,100
-92,700
-93% -$1.06M ﹤0.01% 5605
2021
Q4 		$1.16M Buy
99,800
+60,600
+155% +$743K ﹤0.01% 3201
2021
Q3 		$512K Sell
39,200
-43,500
-53% -$562K ﹤0.01% 4162
2021
Q2 		$1.06M Buy
82,700
+56,800
+219% +$650K ﹤0.01% 3339
2021
Q1 		$290K Buy
25,900
+3,100
+14% +$32.7K ﹤0.01% 4612
2020
Q4 		$260K Buy
22,800
+20,600
+936% +$225K ﹤0.01% 3860
2020
Q3 		$20K Sell
2,200
-32,500
-94% -$323K ﹤0.01% 5126
2020
Q2 		$358K Buy
34,700
+25,700
+286% +$263K ﹤0.01% 2892
2020
Q1 		$91K Sell
9,000
-34,800
-79% -$409K ﹤0.01% 3368
2019
Q4 		$583K Sell
43,800
-15,600
-26% -$172K ﹤0.01% 2313
2019
Q3 		$510K Buy
59,400
+56,500
+1,948% +$549K ﹤0.01% 2311
2019
Q2 		$32K Sell
2,900
-16,204
-85% -$182K ﹤0.01% 3989
2019
Q1 		$216K Buy
19,104
+15,880
+493% +$177K ﹤0.01% 2643
2018
Q4 		$28K Sell
3,224
-48,834
-94% -$560K ﹤0.01% 3859
2018
Q3 		$805K Sell
52,058
-68,417
-57% -$1.08M 0.01% 1875
2018
Q2 		$1.93M Buy
120,475
+118,803
+7,105% +$1.76M 0.02% 1169
2018
Q1 		$22K Sell
1,672
-835
-33% -$10.4K ﹤0.01% 4049
2017
Q4 		$31K Sell
2,507
-10,030
-80% -$131K ﹤0.01% 3967
2017
Q3 		$166K Buy
12,537
+12,298
+5,146% +$169K ﹤0.01% 2897
2017
Q2 		$4K Sell
239
-7,164
-97% -$104K ﹤0.01% 4468
2017
Q1 		$106K Sell
7,403
-72,595
-91% -$993K ﹤0.01% 2936
2016
Q4 		$1.02M Buy
79,998
+10,149
+15% +$128K 0.01% 1307
2016
Q3 		$929K Sell
69,849
-23,522
-25% -$275K 0.01% 1328
2016
Q2 		$1.02M Buy
93,371
+24,119
+35% +$236K 0.01% 1241
2016
Q1 		$635K Buy
69,252
+44,178
+176% +$364K 0.01% 1512
2015
Q4 		$243K Buy
25,074
+19,820
+377% +$192K ﹤0.01% 2353
2015
Q3 		$46K Sell
5,254
-2,507
-32% -$23.4K ﹤0.01% 3574
2015
Q2 		$78K Sell
7,761
-35,223
-82% -$409K ﹤0.01% 3247
2015
Q1 		$576K Sell
42,984
-4,179
-9% -$54.8K 0.01% 1487
2014
Q4 		$605K Sell
47,163
-7,045
-13% -$80.6K 0.01% 1413
2014
Q3 		$588K Sell
54,208
-56,118
-51% -$642K 0.01% 1502
2014
Q2 		$1.42M Buy
110,326
+60,894
+123% +$662K 0.02% 917
2014
Q1 		$510K Sell
49,432
-20,298
-29% -$228K 0.01% 1632
2013
Q4 		$678K Sell
69,730
-12,895
-16% -$116K 0.01% 1416
2013
Q3 		$820K Buy
82,625
+45,611
+123% +$447K 0.02% 1166
2013
Q2 		$308K Buy
+37,014
New +$449K 0.01% 1768

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Group One Trading's IRWD Position: Q1 2025 in Review

Group One Trading sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2025, closing a stake of 1,403 shares — an estimated $3.34K sold.

Group One Trading first reported a position in IRWD in Q2 2013 and held it in 26 quarters. The position peaked at $795K in Q1 2014. 200 funds tracked by Wall St. Rank hold IRWD as of Q1 2025.

  • Group One Trading reported no remaining Ironwood Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Group One Trading sold 1,403 Ironwood Pharmaceuticals shares in Q1 2025, an estimated $3.34K.
  • Group One Trading first reported a position in Ironwood Pharmaceuticals in Q2 2013 and held it in 26 quarters.
  • Group One Trading's Ironwood Pharmaceuticals position peaked at $795K in Q1 2014.
  • 200 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2025.

Based on Group One Trading's 13F filing for Q1 2025, filed 14 May 2025.